• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Epha1

Eps15 homology domainCcontaining 2 (EHD2) is one of the EHD-containing protein

January 15, 2019 by Katherine Lewis Leave a Comment

Eps15 homology domainCcontaining 2 (EHD2) is one of the EHD-containing protein category of dynamin-related ATPases involved with membrane redesigning in the endosomal system. is necessary for caveolar localization. EHD2 had not been needed for the development or shaping of caveolae, but high degrees of EHD2 triggered distortion and lack of endogenous caveolae. Set up of … [Read more…]

Posted in: Blogging Tagged: Epha1, Tedizolid

Rationale and Goals Determine inter- and intraobserver variability of computed tomography

May 31, 2017 by Katherine Lewis Leave a Comment

Rationale and Goals Determine inter- and intraobserver variability of computed tomography (CT) tumor quantity measurements in advanced non-small-cell lung cancers (NSCLC) sufferers treated within Elvitegravir a Stage II clinical trial using upper body CT. separately measured the tumor size CT and volume attenuation coefficient using commercially available volume analysis software. Concordance relationship coefficients (CCCs) and … [Read more…]

Posted in: DNA Topoisomerase Tagged: Elvitegravir, Epha1

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by